Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Lupus & Nightmares

Lara C. Pullen, PhD  |  Issue: November 2024  |  November 11, 2024

In some cases, says Dr. D’Cruz, pediatric patients spontaneously mention that they have “pretty scary nightmares.” He often asks those patients if they hear voices, and sometimes, in response, he says, “It all comes tumbling out.”

Absent such an obvious opening, he recommends rheumatologists begin by asking patients about their sleep. If patients mention nightmares, then the next step is to ask if the patient has experienced nightmares while awake (i.e., daymares). This can lead to a discussion of visual, auditory, tactile, or olfactory hallucinations.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Both Dr. D’Cruz and Dr. Sloan believe such specific questioning in the clinic, using non-judgmental and nonthreatening language, may reveal that neuropsychiatric symptoms are far more frequent than previously reported.3 Once revealed, the symptoms can be treated. “These young people can bounce back really quickly,” says Dr. D’Cruz, if they receive the appropriate treatment.

Bottom Line

It’s important for patients to learn about their unique progression of symptoms, explains Dr. Sloan. For example, one patient may experience increased nightmares and tremors and feel spaced out before a flare, and another may feel manic and anxious and experience a loss of balance.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“As with many of these symptoms, increasingly disrupted dreaming sleep seems to be an indication of an impending flare in some patients,” says Dr. Sloan.

If patients can recognize and communicate a pattern to their rheumatologists, preempting or reducing a disease flare-up may be possible. Such conversations can be used to build treatment plans and physician-patient trust, leading to much-improved lives for many patients.

“Lupus really is a multi-system disease,” says Dr. D’Cruz. “Listen to the patient. … Try and put it all together, and make a story out of it. … Neuropsychiatric lupus is not all gloom and doom.”


Lara C. Pullen, PhD, is a medical writer based in the Chicago area.

References

  1. Sloan M, Bourgeois JA, Leschziner G, et al. Neuropsychiatric prodromes and symptom timings in relation to disease onset and/or flares in SLE: Results from the mixed methods international INSPIRE study. EClinicalMedicine. 2024 Jul;73:102634.
  2. Sloan M, Wincup C, Harwood R, et al. Prevalence and identification of neuropsychiatric symptoms in systemic autoimmune rheumatic diseases: An international mixed methods study. Rheumatology (Oxford). 2024 May 2; 63(5):1259–1272.
  3. D’Cruz DP, Sloan M. Clinical observation: Are nightmares a manifestation of neuropsychiatric lupus? Rheumatology (Oxford). 2023 Jun; 62(6):2030–2031.

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:ConditionsPatient PerspectiveSystemic Lupus Erythematosus Tagged with:Neurologyneuropsychiatricneuropsychiatric lupusSLE Resource Centersuicide

Related Articles

    Lupus in the Child’s Mind

    March 1, 2009

    Unique neuropsychiatric problems require a unique approach

    Lupus often presents with a butterfly rash.

    Top 12: Research in Systemic Lupus Erythematosus at a Glance

    November 18, 2021

    Dr. Pisetsky’s picks for the top research in lupus presented at ACR Convergence 2021.

    A Better Family Plan

    October 1, 2007

    How to minimize the risks of pregnancy for women with SLE

    T Cells in Systemic Lupus Erythematosus

    August 1, 2011

    Progress toward targeted therapy

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences